2Koprowski H,Steplewoki Z, Mitchell K, et al. Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Gen,1979,5(6) :957.
3Nilsson O, Johansson C, Glimelius B, et al. Sensitivity and specifity CA242 in gastrointestinal cancer:a comparison with CEA,CA250 and CA19-9. Br J Cancer,1992,65(2) :215.
4Matthias W. The role of CEA for the dection of recurrent disease following curative resection of large-bowel cancer. Langenbeck's Archives of Surgery. 2000, 385(4):271.
5Kuusels, Haglund C, Roberts PJ. Comparison of a new tumor marker CA242 with CA19-9, CA50 and CEA in digestive tract disease. Br J Cancer. 1991, 63(4):636.
6Claudio Bassi. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, CA19-9, CA125, CA15-3. Langenbeck's Archives of Surgery. 2002, 387:281.
7Gebauer G, Muller RW. Carcinoembryonic antigen and CA19-9: implication of quantitative marker measurement in tissues for prognosis of colorectal cancer. Cancer Detect Prev. 2001,25:344.
8Beart RW,O'Connell MJ.Postoperative follow-up of patients with carcinoma of the colon[J].Mayo Clinic Proceedings,1983,58(6):361-363.
9Durdey P,Williams NS.Pre-operative evaluation of patients with low rectal carcinoma[J].World Journal of Surgery,1992,16(3):430-436.
8Kai AJ,Chan DW.Cancer proteomics;serum diagnostic for tumor marker discovery[J].Ann NY Acad Sci,2004,1022:286.
9Kilima F;takao.Detevtion and clinical signficance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma[J],2000(01).
